Abstract
In order to examine the effect of hematopoietic stem cell transplantation (HSCT) on cardiac systolic function, we measured left ventricular ejection fraction (LVEF) by radioventriculography (RVG) before and after the transplantation procedure. One hundred and forty-eight patients were examined, 96 undergoing allogeneic grafting and 52 autologous. Fifty patients had CML, 48 AML, 21 ALL, 18 multiple myeloma and 11 breast cancer. The second RVG examination was performed 22 to 227 days (median 60 days) after HSCT. The mean LVEF value in the whole patient group was 60.2% (range 39–81%) before and 61.1% (35–86%) after transplantation. Patients with CML had significantly higher LVEF before transplantation than patients with acute leukemia (P = 0.007) and multiple myeloma (P = 0.005). No significant changes in mean LVEF between the pre- and post-transplant measurements were seen in any of the diagnostic subgroups or in allogeneic or autologous recipients. None of the 148 patients in the study has shown any signs of clinical heart failure at 2, 5 to 10 years follow-up. Patients who had received anthracyclines in the previous treatment had significantly lower LVEF before transplantation but showed no increased risk of decline in cardiac function. In conclusion, the HSCT procedure does not seem to affect myocardial function 1–7 months after transplantation. Bone Marrow Transplantation (2000) 26, 187–192.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cazin B, Gorin NC, Laporte JP et al. Cardiac complications after bone marrow transplantation. A report on a series of 63 consecutive transplantations Cancer 1986 57: 2061–2069
Hertenstein B, Stefanic M, Schmeiser T et al. Cardiac toxicity of bone marrrow transplantation: predictive value of cardiologic evaluation before transplant J Clin Oncol 1994 12: 998–1004
Kupari M, Volin L, Suokas A et al. Cardiac involvement in bone marrow transplantation: serial changes J Intern Med 1990 227: 259–266
Bernuth G, Adam D, Hofstetter R et al. Cyclophosphamide cardiotoxicity Eur J Ped 1980 134: 87–90
Goldberg MA, Antin JH, Guinan EC et al. Cyclophosphamide cardiotoxicity: an analysis of dosing as a risk Blood 1986 68: 1114–1118
Gottdiener JS, Appelbaum FR, Ferrans VJ et al. Cardiotoxicity associated with high-dose cyclophosphamide therapy Arch Intern Med 1981 141: 758–763
Mills BA, Roberts RW . Cyclophosphamide-induced cardiomyopathy Cancer 1979 43: 2223–2226
Steinhertz LJ, Steinhertz PG, Mangiacasale D et al. Cardiac changes with cyclophosphamide Med Ped Oncol 1981 9: 417–422
von Hoff DD, Rozencweig M, Piccart M . The cardiotoxicity of anticancer agents Semin Oncol 1982 39: 23–33
Ali MK, Kahlil KG, Fuller LM et al. Radiation-related myocardial injury. Management of two cases Cancer 1976 38: 1941–1946
Cohn KE, Stewart JR, Fajardo LF et al. Heart disease following radiation Medicine 1967 46: 281–298
Fajardo LF, Stewart JR, Cohn KE . Morphology of radiation-induced heart disease Arch Pathol 1968 86: 512–519
Muggia FM, Cassileth PA . Constrictive pericarditis following radiation therapy Am J Med 1968 44: 116–123
von Hoff DD, Layard MW, Basa P et al. Risk factors for doxorubicine induced congestive heart failure Ann Intern Med 1979 91: 710–717
Stewart JR, Fajardo LF . Radiation-induced heart disease: an update Prog Cardio Dis 1984 17: 173–194
Buja LM, Ferrans VJ, Graw RG Jr . Cardiac pathologic findings in patients treated with bone marrow Hum Pathol 1976 7: 17–45
Doroshow JH . Doxorubicin-induced cardiac damage New Engl J Med 1991 324: 843–845
Lenaz L, Page JA . Cardiotoxicity of doxorubicine and related anthracyclines Cancer Treat Rev 1976 3: 111–120
von Hoff D, Rosencweig M, Layard M et al. Daunorubicin-induced cardiotoxicity in children and adults Am J Med 1977 62: 200–208
Schwartz GR, McKenzie WB, Alexander J et al. Congestive heart failure and left ventricular ejection fraction complicating doxorubicin therapy Am J Med 1987 82: 1109–1118
Ljungman P, Björkstrand B, Garthon G et al. High-dose chemotherapy in breast cancer. Promising results in combination with stem cell support (in Swedish) Läkartidningen 1995 92: 851–853
Antman K, Ayash L, Elias A et al. High-dose cyclophosphamide, thiotepa and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy: analysis by age J Natl Cancer Inst 1994 16: 91–94
Björkstrand B, Ljungman P, Bird JM et al. Double high-dose chemoradiotherapy with autologous stem cell transplantation can induce molecular remission in multiple myeloma Bone Marrow Transplant 1995 15: 367–371
Praga C, Beretta G, Vigo PL et al. Adriamycin cardiotoxicity: a survey of 1273 patients Cancer Treat Rep 1979 63: 827–834
Hollingshead LM . Idarubicin: a review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the chemotherapy of cancer Drugs 1991 42: 690–718
Neri B, Ciui-Neri C, Bandinelli H et al. Doxorubicin and epirubicin cardiotoxicity: experimental and clinical aspects Int J Clin Pharmacol Ther Tox 1989 27: 217–221
Alexander J, Dainiak N, Berger HJ et al. Serial assessment of doxorubicin cardio toxicity with quantitative radionuclide angiocardiography New Engl J Med 1979 300: 278–283
Schwartz RG, McKenzie WB, Alexander J et al. Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography Am J Med 1987 82: 1109–1118
Kupari M, Volin L, Suokas A et al. Cardiac involvement in bone marrow transplantation Bone Marrow Transplant 1990 5: 91–98
Carlsson K, Smedmyr B, Bäcklund L et al. Subclinical disturbances in cardiac function at rest and in gas exchange during exercise are common findings after autologous bone marrow transplantation Bone Marrow Transplant 1994 14: 949–954
Burow RD, Strauss HW, Singleton R et al. Analysis of left ventricular function from multiple gated acquisition cardiac blood pool imaging. Comparison to contrast angiography Circulation 1977 56: 1024–1028
Folland ED, Hamilton GW, Larson SM et al. The radionuclide ejection fraction: a comparison of three radionuclide techniques with contrast angiography J Nucleic Med 1977 18: 1159–1166
Marshall RC, Berger HJ, Reduto LA et al. Variability in sequential measures of left ventricular performance assessed with radionuclide angiocardiography Am J Cardiol 1978 41: 531–536
Wackers FJ, Berger HJ, Johnstone DE et al. Multiple gated cardiac blood pool imaging for left ventricular ejection fraction: validation of the technique and assessment of variability Am J Cardiol 1979 43: 1159–1166
Marshall RC, Berger HJ, Costin JC et al. Assessment of cardiac performance with quantitative radionuclide angiocardiography: sequential left ventricular ejection fraction, normalized left ventricular ejection rate, and regional wall motion Circulation 1977 56: 820–829
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lehmann, S., Isberg, B., Ljungman, P. et al. Cardiac systolic function before and after hematopoietic stem cell transplantation. Bone Marrow Transplant 26, 187–192 (2000). https://doi.org/10.1038/sj.bmt.1702466
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1702466
Keywords
This article is cited by
-
Late cardiac events after allogeneic stem cell transplant: incidence, risk factors, and impact on overall survival
Cardio-Oncology (2023)
-
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA)
Annals of Hematology (2023)
-
Cardiovascular disease and its management in children and adults undergoing hematopoietic stem cell transplantation
Journal of Thrombosis and Thrombolysis (2021)
-
Incidence and predictors of severe cardiotoxicity in patients with severe aplastic anaemia after haploidentical haematopoietic stem cell transplantation
Bone Marrow Transplantation (2019)
-
The injured heart: early cardiac effects of hematopoietic stem cell transplantation in children and young adults
Bone Marrow Transplantation (2017)